_Reagents_And_Kits.jpg)
Enzyme Immunoassay (EIA) test is one of laboratory technology that is used for measuring the concentration of analytes such as antigen and antibodies in solution. Enzyme Immunoassay (EIA) test includes various types of enzymes such as alkaline phosphatases, glucose oxidase, and carbonic anhydrase the result can be detected by fluorometry or photometry. Enzyme Immunoassay (EIA) is used as a screening test in the treatment of various infectious diseases such as otavirus, syphilis, Rocky Mountain spotted fever, pernicious anemia, and HIV AIDS. Enzyme Immunoassay (EIA) finds application in different healthcare facilities that includes diagnostic laboratories, hospital, and research laboratories. In addition, Enzyme Immunoassay (EIA) is used in academics, and food industry for different applications.
Increasing incidence of diseases such as infectious diseases and cancer is one of the primary driver associated with the growth of global Enzyme Immunoassay (EIA) Reagents and Kits market. Also, continuous development in biomarkers, cost benefit as compared to other diagnostic tests, and increasing adoption of automated platforms for Enzyme Immunoassay (EIA) has led to increasing demand for Enzyme Immunoassay (EIA) test on the market.Based on the product type, market has been segmented into reagents and kits. In terms of technology, enzyme Immunoassays are further classified into competitive ELISA, indirect ELISA, sandwich ELISA, and multiple/portable ELISA. Based on application, Enzyme Immunoassay (EIA) Reagents and Kits market categorised into Infectious diseases, Cardiology, Oncology, Bone and Mineral, Autoimmunity, Endocrinology, Toxicology, Neonatal screening, Hematology, and Others. In term of end-user, the market has been segmented into hospital laboratories, clinical laboratories, pharmaceutical & biotechnology companies, reference laboratories, academics and others.
At regional level, global Enzyme Immunoassay (EIA) Reagents and Kits market has been segmented into North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. In terms of revenue, North America is major contributor for Enzyme Immunoassay (EIA) test products. Higher adoption of new technologically advanced products and rising awareness for early disease diagnosis propels market growth in the region. Increasing awareness of diseases among peoples that leads to regular check-ups for disease management drives the Enzyme Immunoassay (EIA) test market in North America. The market in North Americas is expected to sustain its growth in the forecast period. North America is followed by Europe which is second largest revenue contributor for global Enzyme Immunoassay (EIA) Reagents and Kits market. The market in Europe is growing steadily because of high prevalence and incidence of disease in the region. Also, the presence of well-established diagnostic laboratories that offers fully automated Enzyme Immunoassay (EIA) test systems with increased efficiency of tests. Asia Pacific is third promising revenue contributor which is expected to grow at rapid pace in upcoming year. Countries such as Japan, India and China are major contributors for this market. Emerging and huge population base countries such as China and India offers tremendous market opportunities. Many global manufacturers are trying to capture this market.
